The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PSA progression compared to radiographic or clinical progression in metastatic castration-resistant prostate cancer patients treated with enzalutamide.
 
Shruti U. Gandhy
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Jennifer L. Marte
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst)
 
Sheri McMahon
No Relationships to Disclose
 
Julius Strauss
Research Funding - EMD Serono (Inst); Etubics (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on NIH pending patent (Inst)
 
Anna Couvillon
No Relationships to Disclose
 
Monique Williams
No Relationships to Disclose
 
Amy Hankin
Stock and Other Ownership Interests - Amgen; Medtronic
 
Seth M. Steinberg
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - have patents held by Precision Biologics
 
William L. Dahut
No Relationships to Disclose
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); NantBioScience (Inst); Pfizer (Inst)
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)